Early α-synuclein pathology induces disease-associated microglia and non-cell-autonomous alteration of midbrain dopamine neurons

Parkinson’s disease (PD) is characterised by alpha-synuclein (α-syn) aggregation, degeneration of midbrain dopamine (mDA) neurons, and neuroinflammation. Here, we investigated the ventral midbrain of mice heterozygous for an aggregation-prone mutated form of human α-syn(3K-hα-syn) expressed via the Thy1 promoter. Immunohistochemical analysis revealed that 3K-hα-syn accumulated predominantly in non-dopaminergic neurons of the ventral midbrain, most notably within the red nucleus, while neighbouring mDA neurons showed no detectable transgene expression or phosphorylated α-syn. Despite this, robust microgliosis was observed broadly in the ventral midbrain. Single-nucleus RNA sequencing of mDA neurons demonstrated preserved mDA neuron subtype architecture but selective induction of cholesterol biosynthesis pathways together with downregulation of synaptic gene programmes. In parallel, single-cell RNA sequencing of CD45 + immune cells from the ventral midbrain revealed a transition towards a disease-associated microglial (DAM) state characterised by upregulation of Apoe, Lgals3, Fabp5 , and inflammation-associated pathways. Histological analysis showed that Galectin-3-positive DAM accumulated over time in regions with pronounced levels of phosphorylated α-syn. Finally, pharmacological depletion of microglia using the colony-stimulating factor 1 receptor (CSF1R) inhibitor PLX3397 selectively worsened beam-traversal performance in female 3K het mice, supporting a sex-dependent protective contribution of microglia. Together, these findings demonstrate pathological α-syn accumulation coinciding with widespread microglial activation and suggest that microglia can exert context- and sex-dependent beneficial effects during early stages of 3K-hα-syn-driven neuropathology.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11539990/v1
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Early α-synuclein pathology induces disease-associated microglia and non-cell-autonomous alteration of midbrain dopamine neurons

Linda Gillberg, Thomas Perlmann, Per Svenningsson, Silke Nuber et al.
Research Square
Parkinson's Disease Mechanisms and Treatments
preprint

Early α-synuclein pathology induces disease-associated microglia and non-cell-autonomous alteration of midbrain dopamine neurons

Linda Gillberg, Thomas Perlmann, Per Svenningsson, Silke Nuber, Niclas Branzell, Laura Lahti, Dennis Selkoe, Isabel Hemming, Behzad Yaghmaeian-Salmani
preprint en

Abstract

Parkinson’s disease (PD) is characterised by alpha-synuclein (α-syn) aggregation, degeneration of midbrain dopamine (mDA) neurons, and neuroinflammation. Here, we investigated the ventral midbrain of mice heterozygous for an aggregation-prone mutated form of human α-syn(3K-hα-syn) expressed via the Thy1 promoter. Immunohistochemical analysis revealed that 3K-hα-syn accumulated predominantly in non-dopaminergic neurons of the ventral midbrain, most notably within the red nucleus, while neighbouring mDA neurons showed no detectable transgene expression or phosphorylated α-syn. Despite this, robust microgliosis was observed broadly in the ventral midbrain. Single-nucleus RNA sequencing of mDA neurons demonstrated preserved mDA neuron subtype architecture but selective induction of cholesterol biosynthesis pathways together with downregulation of synaptic gene programmes. In parallel, single-cell RNA sequencing of CD45 + immune cells from the ventral midbrain revealed a transition towards a disease-associated microglial (DAM) state characterised by upregulation of Apoe, Lgals3, Fabp5 , and inflammation-associated pathways. Histological analysis showed that Galectin-3-positive DAM accumulated over time in regions with pronounced levels of phosphorylated α-syn. Finally, pharmacological depletion of microglia using the colony-stimulating factor 1 receptor (CSF1R) inhibitor PLX3397 selectively worsened beam-traversal performance in female 3K het mice, supporting a sex-dependent protective contribution of microglia. Together, these findings demonstrate pathological α-syn accumulation coinciding with widespread microglial activation and suggest that microglia can exert context- and sex-dependent beneficial effects during early stages of 3K-hα-syn-driven neuropathology.

Research Square
Brigham and Women's Hospital (US), Karolinska Institutet (SE)
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon